Anika Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards, Foreign
Anika Therapeutics, Inc. (ANIK) had Deferred Tax Assets, Operating Loss Carryforwards, Foreign of $1.81 million as of 2019-12-31, per its 10-K filed 2020-03-06.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign · last filed 2020-03-06
- 2019-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $1.81M.
- 2018-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $1.38M.
- 2017-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $959.00K.
- 2016-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $1.25M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Foreign | Deferred Tax Assets, Operating Loss Carryforwards, Foreign as first filed |
|---|---|---|
| 2019-12-31 | $1.81M 10-K · filed 2020-03-06 | |
| 2018-12-31 | $1.38M 10-K · filed 2020-03-06 | |
| 2017-12-31 | $959.00K 10-K · filed 2019-02-27 | |
| 2016-12-31 | $1.25M 10-K · filed 2018-02-27 | |
| 2015-12-31 | $1.57M 10-K · filed 2017-02-24 | |
| 2014-12-31 | $2.29M 10-K · filed 2016-03-10 | $2.29M 10-K · filed 2015-03-13 |
| 2013-12-31 | $2.58M 10-K · filed 2015-03-13 | |
| 2012-12-31 | $2.52M 10-K · filed 2014-03-13 | |
| 2011-12-31 | $1.84M 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |